Featured Research

from universities, journals, and other organizations

Community-acquired MRSA cases on the rise in New York City, study suggests

Date:
June 12, 2012
Source:
Society for Healthcare Epidemiology of America
Summary:
Hospitalization rates in New York City for patients with community-acquired methicillin-resistant Staphylococcus aureus, a potentially deadly bacterial infection that is resistant to antibiotic treatment, more than tripled between 1997 and 2006, according to a new report.

Hospitalization rates in New York City for patients with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), a potentially deadly bacterial infection that is resistant to antibiotic treatment, more than tripled between 1997 and 2006, according to a report published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

Most cases of MRSA are acquired in hospitals, nursing homes, or other healthcare facilities. But in recent years public health experts have become increasingly concerned about MRSA infections acquired in community settings like homes, schools, and neighborhoods.

During the study period 3,579 people were admitted to New York City hospitals with CA-MRSA. The rate of CA-MRSA increased from 113 people in 1997, a rate of about 1.5 cases per 100,000 people, to 875 admissions in 2006, a rate of 5.3 per 100,000. Overall, about 20 percent of all MRSA hospitalizations over the study period were community acquired, the study found.

"These findings suggest a substantial increase in the rate of hospitalization with community-acquired MRSA in New York City since 1997," said Amanda Farr, MPH, one of the study's authors. This research was done in collaboration between the New York City Department of Health and Mental Hygiene and Columbia University's Mailman School of Public Health.

When compared with other hospitalizations in the study period, researchers noted that men, children, people with diabetes, people with HIV, and the homeless were more likely to be hospitalized with CA-MRSA than the general population. Residents of the Bronx also had substantially higher rates of CA-MRSA hospitalization than those of other New York City boroughs, likely impacted by a lack of access to primary care health services.

The authors speculated at the increased risk associated with these demographics and co-morbidities. Skin infections and sores are common among people with HIV and diabetes and could open the door to MRSA infection. Males and children may be at higher risk because they are more likely to play contact sports, which are associated with an increase risk of spreading bacteria. Persons that are homeless may have limited access to healthcare, as well as have other risk factors such as lack of personal hygiene and sharing personal items in shelter settings.

The findings suggest that public health efforts to curb community-acquired MRSA should be targeted to high-risk groups.

"Departments of health should educate homeless shelters about CA-MRSA, ways to recognize exposures that lead to transmission and signs and symptoms that should prompt people to seek medical care," the researchers write. "Programs to increase awareness are also needed in the Bronx and other high-risk areas to help residents and healthcare providers recognize signs and symptoms of early infection and implement prompt treatment as well as conduct proper wound care, especially in HIV-positive persons and those with diabetes."

The study reviewed administrative data submitted to New York State Department of Health's Statewide Planning and Research Cooperative System, a reporting system established in 1979 as a result of cooperation between the healthcare industry and government.


Story Source:

The above story is based on materials provided by Society for Healthcare Epidemiology of America. Note: Materials may be edited for content and length.


Journal Reference:

  1. Amanda M. Farr, Brandon Aden, Don Weiss, Denis Nash, and Melissa A. Marx. Trends in Hospitalization for Community-Associated Methicillin-Resistant Staphylococcus aureus in New York City, 1997–2006: Data from New York State’s Statewide Planning and Research Cooperative System. Infection Control and Hospital Epidemiology, 33:7 (July 2012)

Cite This Page:

Society for Healthcare Epidemiology of America. "Community-acquired MRSA cases on the rise in New York City, study suggests." ScienceDaily. ScienceDaily, 12 June 2012. <www.sciencedaily.com/releases/2012/06/120612144757.htm>.
Society for Healthcare Epidemiology of America. (2012, June 12). Community-acquired MRSA cases on the rise in New York City, study suggests. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2012/06/120612144757.htm
Society for Healthcare Epidemiology of America. "Community-acquired MRSA cases on the rise in New York City, study suggests." ScienceDaily. www.sciencedaily.com/releases/2012/06/120612144757.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins